Male Breast Cancer Completed Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00098605Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain MetastasesTreatment